Intro to Antimicrobials Flashcards
Antimicrobial Hx
- Antibiotic: cmpd produces by living microorganism w/ antimicrobial activity
- Synthetic cmpds
A. Not true antibiotics
B. Rational drug design, cmpd screening, serendipity
Factors influencing MIC/MBC
- MIC/MBC not best indicator of clinical efficiency
- Antimicrobials must reach MIC/MBC at site to cause infection
- Challenge
A. Absorption and distribution
B. Bone, CNS, adipose
Effective dose must balance toxicity
- Mechanism targeted has similar mammalian counterpart
A. Mitochondria, protein synthesis - Off-target effects
Non-dose dependent toxicity
- Allergic rxns
2. Idiosyncratic - pharmacogenomic
Bacteriocidal
Kills microbe
Basteriostatic
Stops growth
1. Can -> resistance in immunocompromised pts.
Chemotherapeutic spectrum
Range of organisms antimicrobial can fight
Broad spectrum
Wide range
1. Gram (+) and (-) and some parasites
Narrow spectrum
Few organisms
Extended spectrum
Intermediate range
1. Usually narrow modified to include more
Protein synthesis inhibitors
1. 30S subunit A. Tetracycline B. Aminoglycosides 2. 50S subunit A. Macrolides B. Clindamycin C. Linezolid D. Chloramphenicol E. Streptogramins 3. Bacteriostatic
Resistance mech to protein synthesis inhibitors
1. Dec. porins A. Gram (-) 2. Inc. export of drug by efflux pumps 3. Microbial enzymes alter/destroy drug 4. Alter target proteins 5. Alter targeted pathways
Ways translation is inhibited by antimicrobials
- Drugs bind ribosomes
A. Prevent translocation (erythromycin)
B. Disrupt tRNA interaction (tetracycline) - Prevent peptide chain formation
A. Chloramphenicol
Cell wall synthesis inhibitors
1. Mech: prevent peptidoglycan formation A. Prevent cross-linking 1. Transpeptidase links D-alanine on Muriel monomers 2. Destabilization = bactericidal A. H2O in -> cell bursts B. Most effective in growing pop 3. Beta lactams 4. Glycopeptides 5. Lipopeptides 6. Bacitracin 7. Polymyxins
Beta lactams
Largest class
- Penicillins
- Cephalosporins (biggest subclass)
- Carbapenems
- Monobactams
Penicillins
Beta lactam 1. Natural: gram (+) and syphilis 2. Extended: gram (+) and (-) A. Aminopenicillins B. Amoxicillin C. Ampicillin
Cephalosporins
Beta lactam, biggest subclass
- 5 generations: altered spectra and resistance to degradation by some bacteria
- Ceph or cef in name
Carbapenems
Beta lactam
- Combo therapy common
- Potent
- Broad spectrum
Monobactams
- Not true beta lactams (missing a ring)
2. Narrow spectrum: gram (-)
Allergic response to beta lactams
- Beta lactams + human protein -> allergic response
A. Anaphylaxis
B. Cytolytic anemia - Allergy = contradiction for using any beta lactam
A. Exception: monobactams usually safe
Bacterial resistance to beta lactams
- Open ring -> inactive
- Strategies to combat lactamases
A. Combo therapy: stronger given w/ weaker one- Weak competitively inhibits lactamases
- Strong allowed to work
- Ex: amoxicillin/clavulanate
B. Chem mod of antibiotic to change enzyme affinity to access to ring - Steric hinderance
- Ex: methicillin
Glycopeptides
- Bind D-alanine needed for peptidoglycan crossing
- One of last effective drugs against MRSA infections
- Vancomycin
A. Only gram (+)
B. Resistant organisms don’t use D-alanine
Lipopeptides
Daptomycin 1. Insert into plasma membrane -> disrupt wall A. Gram (+) B. Vancomycin-resistant strains C. Bactericidal
Bacitracin
- Prevents peptidoglycan subunits transfer to cell surface
2. Bactericidal
Polymyxins
Small, (+) peptides
- Disrupt membrane structures
- Bactericidal
- Gram (-)
DNA/RNA stability and synthesis inhibitors
- Direct= bactericidal
A. Target polymerase
B. Target stability/structure of DNA
C. Resistance- Antibiotic modification
- Altered protein targets
- Protective proteins
- Indirect = bacteriostatic
A. Competitive folate synthesis inhibitors
B. Act syngergistically- Sulfonamide: inhibit dihydropteroate synthesis
- Trimethoprim: inhibit dihydrofolate reductase
C. Resistance: inc. bioavailability of precursors
- Broad spectrum
Reasons to use combo therapy
- Broad spectrum therapy in seriously ill pts
- Treat polymicrobial infection
- Dec. emergence of resistant and multi-drug resistant strains
- Dec dose-related toxicity
- Inc inhibition/killing
Additive effects
- Beta-lactamase inhibitors + beta-lactam drugs
A. Amoxicillin/clavulanate
Antagonistic effects
- Bacteriostatic + cell way synth inhibitors
A. Tetracycline dec efficiency of penicillins